Deepgenomics.com Website Review

revolutions in ai, biology and automation are enabling a new approach to medicine. de*p genomics is at the forefront.. the future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. our ai platform rapidly directs us to the best drug candidates. it knows cell biology, right down to the level of dna, rna and the molecular machinery of the cell. everyone at de*p genomics uses the platform to do their work, and everyone participates in improving the platform. that includes our geneticists, biologists, chemists, toxicologists and drug developers. now, we’re creating new oligonucleotide therapies, designed up front to be effective and safe.. smart drug design is about predicting outcomes up front. that's what our ai platform does best, and saturn is the proof. a library of 1000 compounds that are experimentally verified to manipulate cell biology as intended. think of it as a toolkit for controlling cell biology along crucial pathways, rapidly unlocking therapies with greater potential. “canada’s ai explosion: visit three labs where machines are being taught to think like people” “khosla backs ai startup creating new clas* of genetic drugs” september 25, 2017 “the basic fact is no human or group of humans will ever understand how the genome works” “the next blockbuster drug could be developed with help from machine learning techniques” we are looking for individuals who are inspired to join us in building a new kind of world-clas* genetic medicine company. de*p genomics to collaborate with wave life sciences to discover novel therapies for genetic neuromuscular disorders de*p genomics to identify oligonucleotide candidates for treating genetically defined metabolic and neurodegenerative disorders equity investment by khosla ventures, true ventures and bloomberg beta will be used to direct platform to drug discovery mars centre, 661 university avenue, suite 480 toronto, ontario, canada, m5g 1m1